Sees FY24 EBITDA $850 – $900M…
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch Health price target lowered to $7 from $8 at Truist
- Bausch + Lomb price target raised to $20 from $18 at RBC Capital
- Bausch + Lomb initiated with an Outperform at Raymond James
- Bausch + Lomb price target raised to $15.50 from $15 at Evercore ISI
- Bausch + Lomb Showcases Innovations at EuDEC 2024